Apotex Prices Canadian IPO at CAD$24 Per Share, Targets CAD$1.3B Raise

CAD-6.55%
According to Bloomberg, Apotex Health Corp. is set to price its Toronto Stock Exchange initial public offering at CAD$24 per share, the top of the guidance range. The deal, combining new share issuance and existing shareholder secondary sales, is expected to raise approximately CAD$1.3 billion. The generic pharmaceutical company will trade under the ticker symbol APTX on TSX, marking the largest IPO of its kind in five years.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments